Lawrence Blatt - Chief Executive Officer & Founder @ Aligos Therapeutics

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Exits

Unlock for free

Primary Job Title Chief Executive Officer & Founder
Primary Organization
Aligos Therapeutics

Location Heverlee, Vlaams-Brabant, Belgium
Regions European Union (EU), Europe, Middle East, and Africa (EMEA)
Gender Male

Investor Type
obfuscated
obfuscation
Number of Exits
obfuscated
obfuscation

LinkedIn View on LinkedIn

Lawrence M. Blatt is based out of Heverlee, Vlaams-Brabant and is the Chief Executive Officer and Board of Directors of Aligos Therapeutics and also the Chairman of Onco3R Therapeutics. Lawrence previously worked at Alios BioPharma as a Chief Executive Officer. Lawrence M. Blatt attended Indiana University Bloomington.

Personal Investments

Number of Investments

Lawrence Blatt

invested in

Aligos Therapeutics

obfuscation

. This investment -

Post-IPO Equity - Aligos Therapeutics

- was valued at

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Aligos Therapeutics	—	Post-IPO Equity - Aligos Therapeutics	obfuscated obfuscation

Exits

Number of Exits

Unlock for free

Lawrence Blatt

has

obfuscation

exit -

Aligos Therapeutics

Lawrence Blatt

has

obfuscation

exits. Their most notable exits are

Aligos Therapeutics

Aligos Therapeutics Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.

Jobs

Number of Current Jobs

Number of Past Jobs

Lawrence Blatt

is the

Chief Executive Officer & Founder

Aligos Therapeutics

. Additionally,

Lawrence Blatt

has had

past jobs including

Chief Executive Officer, President

Alios BioPharma

Aligos Therapeutics Chief Executive Officer & FounderMar 2018

Organization Name	Title At Company	Start Date	End Date
Alios BioPharma	Chief Executive Officer, President	Aug 2008	Nov 2014
InterMune	Chief Scientific Officer	2002	2008
SIRNA	Vice President of Research	1998	2002
National Genetics Institute	Vice President, Product Development	1996	1998
Amgen Ventures	Head of Interferon Research, Development Team Leader	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Lawrence Blatt

holds

board and advisor roles as

Chairman

Coultreon Biopharma

and

Chairman of the Board of Directors

Alveo Technologies

Coultreon Biopharma ChairmanJan 8, 2026
Alveo Technologies Chairman of the Board of Directors

Organization Name	Title At Company	Start Date	End Date
Alios BioPharma	Director	—	—

Related Hubs

Hub Name	CB Rank (Hub)
EcoR1 Capital Portfolio Companies	64,712
Wellington Management Portfolio Companies	24,558
Biotechnology Companies (Top 10K)	714
Biotechnology Female Founded Companies	20,598
Oncology Companies With More Than $1M in Revenue	12,605
Oncology Public Companies	16,945
Boxer Capital Portfolio Companies	78,596
Deep Track Capital Portfolio Companies	66,375
Janus Henderson Investors Portfolio Companies	36,688
Biotechnology Public Companies With Less Than $1B in Revenue	7,478